David Arterburn, MD, MPH
@davearterburn
Followers
2K
Following
4K
Media
114
Statuses
3K
Internal medicine doc & researcher @KPWaResearch & @UWMedicine tweets on obesity, diabetes, bariatric surgery, shared decision making & related economics/policy
Seattle, WA
Joined September 2015
Our latest @NIDDKgov study published today in @AnnalsofIM found that total healthcare expenditures decreased substantially after bariatric surgery, primarily due to reductions in pharmacy expenditures, with no significant differences between RYGB and SG
3
10
49
RT @JAMASurgery: Over a long-term follow-up, patients undergoing gastric bypass exhibited a lower rate of MACE compared to those with sleev….
0
8
0
RT @ConscienHealth: Rather quietly this week, @EliLillyandCo announced that it had withdrawn an application to @US_FDA for an indication to….
0
7
0
Leveraging Real-World Evidence to Assess Benefits and Risks of GLP-1-Based Therapies - NEXT WEEK - NIDDK Workshop - Don't Miss It! via @NIDDKgov.
niddk.nih.gov
0
0
2
RT @JAMA_current: Between 2021 and 2024, #semaglutide and #tirzepatide prescriptions in Epic-affiliated health care systems increased sligh….
0
27
0
Safety analysis of compounded GLP-1 receptor agonists: a pharmacovigilance study using the FDA adverse event reporting system
pubmed.ncbi.nlm.nih.gov
Compounded GLP-1 RAs may be associated with a higher odds of AEs, safety concerns, and product quality issues compared to non-compounded products. These findings underscore the importance of cautious...
0
1
2
RT @DanielJDrucker: Towards optimal use of GLP-1 medicines for enhancing pregnancy outcomes
jamanetwork.com
This Viewpoint describes the need for more studies on the best timing for dicontinuation of glucagon-like peptide-1 receptor agonists before pregnancy.
0
17
0
Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States: A Population-Based Cohort Study
acpjournals.org
Background: Recent trends in use of tirzepatide, a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide receptor agonist (RA), versus other glucose-lowering medicat...
0
0
2
Unifying Efforts to Empower Equitable Obesity Care: Synopsis of an American College of Physicians and Council of Subspecialty Societies Summit
acpjournals.org
Obesity is a leading cause of morbidity and mortality with health consequences that crosscut most medical specialties. Despite the emergence of effective and promising new therapies, many impediments...
0
1
3
RT @DanielJDrucker: In a review and meta-analysis of randomized clinical trials, glucose-lowering therapy with GLP1-RAs, but not SGLT2is, w….
jamanetwork.com
This meta-analysis examines the association of cardioprotective glucose-lowering agents, including glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors, with...
0
33
0
Neoadjuvant Semaglutide, Bariatric Surgery Weight Loss, and Overall Outcomes - neoadjuvant semaglutide did not confer benefits for weight loss, diabetes remission, or MBS safety. MBS weight loss significantly less with pre-op semaglutide .
jamanetwork.com
This case-control study examines the use of glucagon-like peptide-1 receptor agonist before metabolic and bariatric surgery and its postoperative outcome.
0
6
15
RT @JAMASurgery: Most viewed in the last 7 days from @JAMASurgery: . Ten-year RCT data show similar long-term weight loss outcomes for roux….
0
5
0
RT @bmj_latest: "We are at risk of designing our obesity strategy around a single drug rather than developing a holistic weight management….
bmj.com
Obesity strategy should not be built around a single drug Tirzepatide (Mounjaro) has had a remarkable journey to prominence since its UK marketing authorisation in 2023.1 Approved for glycaemic...
0
18
0
RT @AnnalsofIM: From the Annals ‘Spotlight on 2024’ collection: A target trial emulation study found #bupropion was consistently associated….
0
3
0
RT @Ali_Aminian_MD: In @DiabetesCareADA today:.In ARMMS-T2D trial, bariatric surgery produced sustained weight loss & improved quality of l….
0
14
0
Physician Burnout is Real. Help Us Understand and Prevent it!.My colleagues at Brown University are recruiting physicians for a study of burnout. See flyer below.
0
1
4
Digital Mindfulness Training for Burnout Reduction in Physicians: Clinician-Driven Approach
pubmed.ncbi.nlm.nih.gov
ClinicalTrials.gov NCT06145425; https://clinicaltrials.gov/study/NCT06145425.
0
0
1
RT @AnnalsofIM: ICYMI: . Healthcare expenditures decreased substantially after bariatric surgery for patients with….
0
9
0
Health-Related Quality of Life and Health Utility After Metabolic/Bariatric Surgery Versus Medical/Lifestyle Intervention in Individuals With Type 2 Diabetes and Obesity: The ARMMS-T2D Study
pubmed.ncbi.nlm.nih.gov
Metabolic surgery produces sustained weight loss and improves PCS, general health, physical functioning, vitality, and HU in individuals with type 2 diabetes and obesity compared with medical therapy...
0
4
10
What Does the Rise of GLP-1 Drugs Mean for Bariatric Surgery?
pubmed.ncbi.nlm.nih.gov
What Does the Rise of GLP-1 Drugs Mean for Bariatric Surgery?
0
0
9
Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes
pubmed.ncbi.nlm.nih.gov
Semaglutide 2.4 mg use as in SELECT is cost-effective at list price, using a $150,000/QALY willingness-to-pay threshold.
0
0
2